Jun 15, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
Trial Compares Ways To Elicit Patient Values About Prostate-Specific Antigen Screenin
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2729329" data-attributes="member: 124445"><p>Michael Patrick Pignone, M.D., M.P.H., of the University of North Carolina, Chapel Hill, and colleagues conducted a randomized clinical in October 2011 in which men underwent a values clarification task and then chose the most important attribute for prostate-specific antigen (PSA) screening. Â? Men must consider how they value different potential outcomes to make good decisions about PSA screening, according to the study. The trial included 911 men (ages 50 to 70 years) from the United States and Australia who had average risk for prostate cancer...<img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/qjreO6f1l3g" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/qjreO6f1l3g/256188.php" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2729329, member: 124445"] Michael Patrick Pignone, M.D., M.P.H., of the University of North Carolina, Chapel Hill, and colleagues conducted a randomized clinical in October 2011 in which men underwent a values clarification task and then chose the most important attribute for prostate-specific antigen (PSA) screening. Â? Men must consider how they value different potential outcomes to make good decisions about PSA screening, according to the study. The trial included 911 men (ages 50 to 70 years) from the United States and Australia who had average risk for prostate cancer...[IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/qjreO6f1l3g[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/qjreO6f1l3g/256188.php]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top